Reshape Biotech
Reshape Biotech is revolutionizing lab automation by providing AI-powered robots and a connected platform that streamlines data collection and analysis for microbiologists. Founded in 2018, the company leverages advanced technology to enhance research efficiency, enabling labs to achieve reproducibility and scale their experiments effectively. With over 45 million experiments analyzed, Reshape empowers scientists to make data-driven decisions faster, ultimately accelerating the pace of biotechnological advancements across various industries.
Reshape Biotech
Reshape Biotech is revolutionizing lab automation by providing AI-powered robots and a connected platform that streamlines data collection and analysis for microbiologists. Founded in 2018, the company leverages advanced technology to enhance research efficiency, enabling labs to achieve reproducibility and scale their experiments effectively. With over 45 million experiments analyzed, Reshape empowers scientists to make data-driven decisions faster, ultimately accelerating the pace of biotechnological advancements across various industries.
TL;DR
Founded: 2018 (Copenhagen)
Product: Automated plate-imaging robots + cloud AI analysis platform
Recent raise(s): Seed ~ $8M (2023); $20M Series A (announced 2024-04-09 / reported 2025-02-17)
Compliance: ISO27001 and SOC 2 Type II (attestations/certification reported)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Laboratory automation and computer-vision-driven analysis for microbiology assays.
Founded
2018
Industry
Biotechnology Research
Tech Stack
Funding Track Record
8.0-8.1M
Seed round reported at approximately $8M
20M
Series A announced to scale U.S. operations and grow product
Investor Signal
“Astanor Ventures (lead reported for Series A) and participation from R7, ACME, Y Combinator, Nicholas Francis, Per Falholt; earlier angels include Charlie Songhurst”